SCHEMBL6986413

SCHEMBL6986413

CC(C)C[C@@H](C(=O)NN)[C@H](C(=O)OC(C)(C)C)C(CNC(=O)c1ccccc1)(CC(C)C)C(=O)Cn1ccnc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 5/20 0.37
TBXAS1 P24557 1/20 0.35
FNTA P49354 1/20 0.35
FNTB P49356 1/20 0.35
PGGT1B P53609 1/20 0.35
CTSS P25774 1/20 0.34
CTSK P43235 1/20 0.34
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NAMPT P43490 3/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C19 P33261 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
MAPK1 P28482 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6987467 0.91 CYP26A1 (0.36) CYP26A1TBXAS1FNTAFNTBPGGT1B
SCHEMBL6988039 0.90 CYP26A1 (0.36) CYP26A1TBXAS1FNTAFNTBPGGT1B
SCHEMBL6981901 0.87 HRH4 (0.39) CYP26A1TBXAS1FNTAFNTBPGGT1B
SCHEMBL7818934 0.80 CTSS (0.37) FNTAFNTBPGGT1BCTSSCTSK
SCHEMBL7808546 0.79 CTSS (0.36) FNTAFNTBPGGT1BCTSSCTSK
SCHEMBL6987186 0.77 TBXAS1 (0.37) TBXAS1KMT2A
SCHEMBL7816001 0.76 CTSK (0.41) CTSSCTSKNPSR1
SCHEMBL6985861 0.72 HMOX2 (0.35) TBXAS1NPSR1
SCHEMBL7836648 0.71 MAPT (0.40) CTSSCTSKMAPTKMT2AMEN1
SCHEMBL7955112 0.71 MAPT (0.40) CTSSCTSKMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1089964-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-10-29 EP disclosed
US-6239151-B1 TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, HOFFMANN-LA ROCHE INC. 2001-05-29 US disclosed